Kirk Ogrosky > Goodwin > Washington DC, United States > Lawyer Profile
Goodwin Offices
1900 N Street NW
Washington, District of Columbia 20036
United States
Kirk Ogrosky
Position
Partner
Career
Kirk Ogrosky is a partner in Goodwin’s Complex Litigation and Dispute Resolution, Life Sciences, and Healthcare practices where he co-leads the firm’s Healthcare Government Enforcement & False Claims Act Defense group. Kirk is recognized as one of the nation’s leading white-collar defense attorneys having first-chaired federal jury trials involving over 40 defendants in districts across the country. Kirk focuses his practice on defending clients accused of healthcare fraud, qui tam litigation involving the Anti-Kickback Statute (AKS); False Claims Act (FCA) defense, as well as Foreign Corrupt Practices Act (FCPA) matters involving healthcare sectors. His clients include pharmaceutical and device manufacturers; clinical laboratories; pharmacies; hospitals and integrated health networks; ambulatory surgery centers; diagnostic testing facilities; skilled nursing facilities; physicians; as well as private equity firms, operating companies and investors in governmental investigations.
Education
JD, The George Washington University Law School 1995 / BA, Washington University (cum laude) 1992
Lawyer Rankings
United States > Dispute resolution > Corporate investigations and white-collar criminal defense
Goodwin defends clients in complex matters, including financial and securities fraud, FCPA violations, healthcare fraud, and whistleblower claims, representing them before agencies like the SEC, DOJ, and CFPB. Notable leaders such as Richard Strassberg in New York, head of the white-collar defense practice, specialize in SEC enforcement, FCPA investigations, and corporate internal investigations. Grant Fondo brings vast experience in governmental investigations, blockchain, and securities litigation, while Kirk Ogrosky focuses on FCPA defense and healthcare-related fraud.
Lawyer Rankings
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation